ALK

• D4802

  17-Dimethylaminoethylamino Demethoxygeldanamycin

  Geldanamycin derivative; HSP90 inhibitor.

  ≥98%
• A001001

  A 83-01

  TGFbeta receptor inhibitor

  ≥98%
• A600002

  AP-26113

  Pan inhibitor of ALK.

  ≥98%
• A7400

  ASP3026

  ALK inhibitor.

  ≥98%
• A9600

  AZD-3463

  ALK and IGF-1R inhibitor.

  ≥99%
• C179602

  CEP-28122

  ALK inhibitor.

  ≥98%
• C179604

  CEP-28122 Mesylate

  ALK inhibitor.

  ≥98%
• C179603

  CEP-37440 Hydrochloride

  Inhibitor of FAK and ALK.

  ≥99%
• C6935

  Crizotinib

  ALK, ROS1, c-MET inhibitor.

  ≥98%
• D490280

  DMH-1

  Inhibitor of BMP.

  ≥99%
• D5868

  Doramapimod

  JNK, ALK, p38 MAPK inhibitor.

  ≥99%
• E543721

  Ensartinib

  A third-generation ALK inhibitor.

  ≥98%
• G7540

  GSK-1838705A

  ALK and IGF-1R inhibitor.

  ≥98%
• G8800

  GW-788388

  ALK5 (activin-like) antagonist.

  ≥97%
• L1340

  LDK378

  ALK and IGF-1R inhibitor.

  ≥99%
• L582694

  Lorlatinib

  Third generation macrocyclic ALK inhibitor.

  ≥98%
• N4974

  NMS-E628

  ALK and Ros1 inhibitor, Trk antagonist.

  ≥98%
• N8760

  NVP-TAE684

  ALK, c-Fes, LRRK2 inhibitor.

  ≥98%
• S0400

  SB-431542

  ALK4/5/7 (activin-like) inhibitor, TGF-β inhib...

  ≥98%

Showing all 19 results